Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
11/2003
11/13/2003US20030212269 Kinase inhibitor; antitumor agents, psoriasis, skin disorders, antiarthritic agents
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/13/2003US20030212111 Controlling concentration of cholesterol, triglyceride, bile acid
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1359892A1 Primary intermediates for oxidative coloration of hair
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/11/2003US6646162 Compounds and compositions for delivering active agents
11/11/2003US6646128 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives
11/11/2003US6646122 Ligand and complex for catalytically bleaching a substrate
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645970 Preventing T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645966 Reverse malaria drug resistance
11/06/2003US20030207896 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/06/2003US20030207887 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
11/06/2003US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
11/05/2003EP1358165A1 Imidazole derivatives
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1153006B1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/05/2003EP1019047B1 Antithrombotic agents
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/04/2003US6642229 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
11/04/2003US6642223 Benzoheterocyclic derivatives
10/2003
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355881A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/28/2003US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638321 Oxidation color dyes for hair from aniline compounds
10/23/2003WO2003087111A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
10/23/2003WO2003087110A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003WO2003087106A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents
10/23/2003WO2003087086A2 Substituted indoles
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086271A2 Azole derivatives as antifungal agents
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent
10/23/2003US20030199530 New compounds derived from quinazoline
10/23/2003US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
10/23/2003CA2482656A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353895A2 Primary intermediates for oxidative coloration of hair
10/22/2003EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
10/22/2003EP0881218B1 Preventives/remedies for complications of diabetes
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/22/2003CN1125023C Substance for inducing cell death
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003CA2103894C Aryl sulphonyl urea compounds, a method of preparing them, and their use as herbicides and growth regulators
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003047512A3 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030195173 Colchinol derivatives as angiogenesis inhibitors
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
10/15/2003EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use
10/15/2003EP0855391B1 Novel isoquinoline derivatives
10/15/2003EP0766674B1 New hiv protease inhibitors
10/15/2003EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449395A Process for preparing azacycloalkanoyl aminothiazoles
10/15/2003CN1449388A Process and intermediates for preparing retroviral protease inhibitors
10/15/2003CN1124267C Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632809 Gyrase inhibitors and uses thereof
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 163